Guías Clínicas 144 GUÍA CLÍNICA DE MANEJO Y TRATAMIENTO DE LA INFECCIÓN POR VIRUS DE LA HEPATITIS B - Ministerio de Salud, Chile the European Concerted action on Viral Hepatitis (EUROHEP). J Hepatol 1994; 21: 656-66. 73.- Fattovich G, Pantalena M, Zagni I, et al. Effect of hepatitis B and C virus infections on the natural history of com-pensated cirrhosis: a cohort study of 297 patients. Am J gastroenterol 2002; 97: 2886-95. 74.- Chu CM, Liaw YF. Hepatitis B virus-related cirrhosis: natural history and treatment. Semin Liver Dis 2006; 26: 142-52. 75.- Liberek A, Luczak G, Gora-Gebka M, Landowski P. Management of chronic hepatitis B in children. Hepatitis B Annual 2006; 3: 106-27. 76.- Kelly D. Viral hepatitis B and C in chil-dren. J Royal Soc Med 2006; 99: 353- 357. 77.- Todo S, et al. Orthotopic liver transplan-tation for patients with hepatitis B virus-related liver disease. Hepatology 1991; 13: 619-26. 78.- Davies SE, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis Hepatology 1991; 13: 150-7. 79.- Samuel D, Samuel D, Muller R, Alexander G, Fassati L, Ducot B, et al. Liver transplantation in European patients with the hepatitis B surface anti-gen. N Engl J Med 1993; 329: 1842-7. 80.- Terrault NA, et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology 1996; 24: 1327-33. 81.- McGory RW, Ishitani MB, Oliveira WM, et al. Improved outcome of or-thotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996; 61: 1358-64. 82.- Gane EJ, Angus PW, Strasser S, Crawford DH, Ring J, Jeffrey GP, McCaughan GW; Australasian Liver Transplant Study Group. Lamivudine plus low-dose hepatitis B immunoglo-bulin to prevent recurrent hepatitis B following liver transplantation. Gastroenterology 2007; 132: 931-7. 83.- Angus P, et al. A randomized study to assess the safety and efficacy of adefovir dipivoxil substitution for hepatitis B immune globulin in liver transplantation patients receiving long-term low dose IM HBIg and lamivudine prophylaxis. Hepatology 2007; 46: A 238. 84.- Gane E, Strasser S, Patterson S, McCaughan G, Angus P. Prospective study on the safety and efficacy of la-mivudine and adefovir prophylaxis in HBsAg positive liver transplantation candidates. Hepatology 2007; 46: A 479. 85.- Castells L, Esteban R. Hepatitis B vacci-nation in liver transplant candidates. Eur J Gastroenterol Hepatol 2001; 13: 359-61. 86.- Mattos AA, Gomes EB, Tovo CV, et al. Hepatitis B vaccine efficacy in patients with chronic liver disease by hepatitis C virus. Gastroenterol 2004; 41: 180-4. 87.- Bonazzi PR, Bacchella T, Freitas AC, et al. Double-dose hepatitis B vacci-nation in cirrhotic patients on a liver transplant waiting list. Braz J Infect Dis 2008; 2008. 88.- Sánchez-Fueyo A, et al. Hepatitis B im-munoglobulin discontinuation followed by hepatitis B virus vaccination: a new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplanta-tion. Hepatology 2000; 31: 496-501. 89.- Angelico M, Di Paolo D, Trinito MO, Petrolati A, Araco A, Zazza S, et al. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis. Hepatology 2002; 35: 176-81. 90.- Terrault N, Roche B, Samuel D. Mana-gement of the hepatitis B virus in the liver transplantation setting: A European and an American perspective. Liver Transplantation 2005; 11: 716-32. 91.- Multimer D. Hepatitis B and liver trans-plantation. Aliment Pharmacol Ther 2006; 23: 1031-41. 92.- Han SH. Extrahepatic manifestations of chronic hepatitis B. Clin Liv Dis 2004; 8: 403-18. 93.- Kim JD, Sherker AH. Antiviral therapy: role in the management of extrahepatic diseases. Gastroenterol Clin N Am 2004; 33: 693-708. 94.- Amarapurkar DN, Amarapurkar AD. Extrahepatic manifestations of viral hepatitis. Ann Hepatol 2002; 1: 192-5. 95.- Cacoub P, Saadoun D, Bourlie`re M et al. Hepatitis B virus genotypes and extrahepatic manifestations. J Hepatol 2005; 43: 764-70. 96.- Wilson RA. Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 1997; 92: 4-17. 97.- Brzosko WJ, Krawczynski K, Nazarewicz T, Morzycka M, Nowoslawski A. Glomerulonephritis associated with hepatitis-B surface antigen immune complexes in children. Lancet 1974; 2: 477-82. 98.- Lai KN, Li PK, Lui SF, et al. Membra-nous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991; 324: 1457-63. 99.- Safadi R, Almog Y, Dranitzki-Elhalel M, Rosenmann E, Tur-Yaspa R. Glomerulo-nephritis associated with acute hepatitis B. Am J Gastroenterol 1996; 91: 138-9. 100.- Lin CY. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int 1995; 47: 225-30. 101.- Gorevic ED, Kassab SJ, Levo E, et al. Mixed cryoglobulinemia: clinical aspects and long term follow up of 40 patients. Am J Medicine 1980; 69: 287- 308. 102.- Dienstag JL, Wands JR, Isselbacher KJ. Hepatitis B and essential mixed cryoglobulinemia. N Engl J Med 1977; 297: 946-7. 103.- Brown KE, Tisdale J, Barrett J, Dunbar CE, Young NS. Hepatitis asso-ciated aplastic anemia. N Engl J Med 1997; 336: 1365-72. 104.- Guillevin L, Llote F, Cohen P, et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long- term observation of 41 patients. Medici-ne 1995; 74: 238-53. 105.- Guillevin L, Lhote F, Sauvaget F, et al. Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis 1994; 53: 334-7. 106.- Kruger M, Boker KH, Zeidler H, Manns MP. Treatment of hepatitis B-related polyarteritis nodosa with famci-clovir and interferon alfa-2b. J Hepatol 1997; 26: 935- 9. 107.- Erhardt A, Sagir A, Guillevin L, Neuen- Jacob E, Haussinger D. Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine. J Hepatol 2000; 33: 677-83. 108.- Gianotti F. Papular acrodermatitis of Gastroenterol. latinoam 2010; Vol 21, Nº 2: 89-147
n1-2010
To see the actual publication please follow the link above